PTC Therapeutics Inc (NASDAQ:PTCT)

60.85
Delayed Data
As of Mar 31
 -4.00 / -6.17%
Today’s Change
14.51
Today|||52-Week Range
77.87
+17.54%
Year-to-Date

Today’s Trading

Previous close64.85
Today’s open64.66
Day’s range-- - --
Volume685,391
Average volume (3 months)578,817
Market cap$2.2B
Dividend yield--
Data as of 03/31/2015

Growth & Valuation

Earnings growth (last year)+42.66%
Earnings growth (this year)-69.98%
Earnings growth (next 5 years)--
Revenue growth (last year)-27.24%
P/E ratioNM
Price/Sales--
Price/Book7.15

Competitors

 Today’s
change
Today’s
% change
MNKDMannkind Corp-0.13-2.44%
RAREUltragenyx Pharmaceu...+1.14+1.87%
CBPOChina Biologic Produ...+3.11+3.37%
--Cosmo Pharmaceutical...+9.35+6.24%
Data as of 4:14pm ET, 03/31/2015

Financials

Next reporting dateMay 5, 2015
EPS forecast (this quarter)-$1.27
Annual revenue (last year)$25.2M
Annual profit (last year)-$93.8M
Net profit margin-371.37%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Stuart W. Peltz
Chief Financial Officer
Shane William Charles Kovacs
Corporate headquarters
South Plainfield, New Jersey

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account